ArticleHeliyon2023

Synergistic efficacy of PI3Kδ inhibitor with anti-PD-1 mAbs in immune-humanized PDX model of endocrine resistance hormone receptor-positive advanced breast cancer.

Yingjue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.